Kunihiko Miyazaki, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 45 | 2024 | 13586 | 1.760 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 22 | 2024 | 5432 | 1.380 |
Why?
|
Spinal Neoplasms | 4 | 2024 | 715 | 0.950 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 102 | 0.820 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2022 | 8 | 0.810 |
Why?
|
Osteolysis | 1 | 2019 | 274 | 0.580 |
Why?
|
Carcinoma, Small Cell | 2 | 2010 | 419 | 0.560 |
Why?
|
Lung Diseases, Interstitial | 3 | 2010 | 940 | 0.530 |
Why?
|
Small Cell Lung Carcinoma | 5 | 2024 | 454 | 0.520 |
Why?
|
Quinazolines | 3 | 2018 | 1373 | 0.490 |
Why?
|
Gait | 1 | 2019 | 823 | 0.440 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5703 | 0.430 |
Why?
|
Adenocarcinoma | 5 | 2022 | 6395 | 0.400 |
Why?
|
Scoliosis | 1 | 2019 | 793 | 0.400 |
Why?
|
Carcinoma, Large Cell | 1 | 2010 | 114 | 0.320 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1627 | 0.310 |
Why?
|
Mutation | 15 | 2024 | 30238 | 0.310 |
Why?
|
Acrylamides | 4 | 2022 | 261 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2024 | 11878 | 0.270 |
Why?
|
Mucin-1 | 1 | 2010 | 537 | 0.240 |
Why?
|
Japan | 2 | 2020 | 1418 | 0.240 |
Why?
|
Gene Rearrangement | 2 | 2020 | 1146 | 0.240 |
Why?
|
Urologic Neoplasms | 1 | 2008 | 314 | 0.230 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2008 | 594 | 0.220 |
Why?
|
Aniline Compounds | 4 | 2022 | 1094 | 0.220 |
Why?
|
Appendiceal Neoplasms | 1 | 2005 | 155 | 0.210 |
Why?
|
Genes, erbB-1 | 2 | 2022 | 163 | 0.200 |
Why?
|
Muscular Dystrophies | 1 | 2005 | 393 | 0.200 |
Why?
|
Aggrecans | 1 | 2022 | 88 | 0.200 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.190 |
Why?
|
Aged, 80 and over | 17 | 2024 | 59629 | 0.190 |
Why?
|
Collagen Type II | 1 | 2022 | 151 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5341 | 0.180 |
Why?
|
Humans | 65 | 2024 | 768166 | 0.170 |
Why?
|
Spinal Cord Compression | 1 | 2022 | 234 | 0.170 |
Why?
|
Neoplasms, Second Primary | 1 | 2008 | 1061 | 0.170 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.170 |
Why?
|
MafB Transcription Factor | 1 | 2019 | 25 | 0.170 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 67 | 0.170 |
Why?
|
Retrospective Studies | 15 | 2024 | 81762 | 0.160 |
Why?
|
Pleural Effusion, Malignant | 1 | 2020 | 108 | 0.160 |
Why?
|
Meningeal Carcinomatosis | 1 | 2019 | 65 | 0.160 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2565 | 0.150 |
Why?
|
Aged | 25 | 2024 | 171504 | 0.150 |
Why?
|
Lung, Hyperlucent | 1 | 2017 | 5 | 0.150 |
Why?
|
Emphysema | 1 | 2020 | 236 | 0.140 |
Why?
|
Kidney Diseases, Cystic | 1 | 2019 | 182 | 0.140 |
Why?
|
Pleural Effusion | 1 | 2020 | 344 | 0.140 |
Why?
|
Middle Aged | 25 | 2024 | 223492 | 0.140 |
Why?
|
Spine | 1 | 2023 | 1140 | 0.130 |
Why?
|
Carboplatin | 2 | 2017 | 797 | 0.130 |
Why?
|
Fatal Outcome | 4 | 2019 | 1836 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2020 | 282 | 0.130 |
Why?
|
RNA Interference | 1 | 2024 | 2832 | 0.130 |
Why?
|
Mycobacterium avium Complex | 1 | 2016 | 66 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2024 | 2457 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2062 | 0.130 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2016 | 82 | 0.130 |
Why?
|
Cervical Vertebrae | 1 | 2021 | 979 | 0.120 |
Why?
|
Cisplatin | 1 | 2020 | 1660 | 0.120 |
Why?
|
Female | 31 | 2024 | 397192 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4058 | 0.110 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2019 | 735 | 0.110 |
Why?
|
Immunotherapy | 3 | 2024 | 4755 | 0.110 |
Why?
|
Male | 27 | 2024 | 364719 | 0.110 |
Why?
|
Prognosis | 8 | 2024 | 30010 | 0.110 |
Why?
|
Pulmonary Eosinophilia | 1 | 2013 | 78 | 0.110 |
Why?
|
China | 1 | 2019 | 2395 | 0.110 |
Why?
|
Palliative Care | 3 | 2024 | 3643 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9419 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2023 | 65371 | 0.100 |
Why?
|
Neoplasm Metastasis | 5 | 2020 | 4912 | 0.100 |
Why?
|
Rats | 3 | 2023 | 23760 | 0.090 |
Why?
|
Biological Products | 1 | 2021 | 948 | 0.090 |
Why?
|
Smoking | 2 | 2024 | 9092 | 0.090 |
Why?
|
Hemoptysis | 1 | 2012 | 152 | 0.090 |
Why?
|
Radiography, Thoracic | 4 | 2020 | 1321 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4352 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2024 | 15832 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13676 | 0.090 |
Why?
|
Adult | 14 | 2024 | 223646 | 0.090 |
Why?
|
Lung | 3 | 2020 | 10099 | 0.090 |
Why?
|
Spinal Fusion | 1 | 2019 | 1307 | 0.080 |
Why?
|
Paclitaxel | 1 | 2017 | 1733 | 0.080 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2009 | 24 | 0.080 |
Why?
|
Carcinoma, Giant Cell | 1 | 2008 | 5 | 0.080 |
Why?
|
Alleles | 1 | 2020 | 6894 | 0.080 |
Why?
|
Paraneoplastic Syndromes | 1 | 2010 | 154 | 0.080 |
Why?
|
Bronchogenic Cyst | 1 | 2008 | 28 | 0.070 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2008 | 43 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6526 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 9 | 2020 | 20760 | 0.070 |
Why?
|
Eosinophils | 2 | 2021 | 952 | 0.060 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 319 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 13014 | 0.060 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2012 | 843 | 0.060 |
Why?
|
Lung Diseases | 1 | 2016 | 1944 | 0.060 |
Why?
|
Exanthema | 1 | 2010 | 503 | 0.060 |
Why?
|
DNA Fragmentation | 1 | 2005 | 240 | 0.060 |
Why?
|
Risk Factors | 5 | 2024 | 74944 | 0.060 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 257 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3252 | 0.050 |
Why?
|
Receptors, Adiponectin | 1 | 2023 | 82 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8080 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6291 | 0.050 |
Why?
|
Signal Transduction | 1 | 2024 | 23645 | 0.050 |
Why?
|
Epidural Space | 1 | 2022 | 123 | 0.050 |
Why?
|
Notochord | 1 | 2020 | 37 | 0.050 |
Why?
|
Child, Preschool | 1 | 2023 | 42669 | 0.040 |
Why?
|
Paralysis | 1 | 2022 | 250 | 0.040 |
Why?
|
Integrin alpha5beta1 | 1 | 2020 | 36 | 0.040 |
Why?
|
Exudates and Transudates | 1 | 2020 | 175 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2204 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2020 | 11244 | 0.040 |
Why?
|
Quinazolinones | 1 | 2021 | 219 | 0.040 |
Why?
|
Gelatin | 1 | 2020 | 231 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 60066 | 0.040 |
Why?
|
Cause of Death | 1 | 2009 | 3721 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2020 | 408 | 0.040 |
Why?
|
Age Distribution | 1 | 2024 | 2873 | 0.040 |
Why?
|
Gene Silencing | 1 | 2024 | 1505 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2005 | 1070 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 719 | 0.040 |
Why?
|
Animals | 4 | 2023 | 169246 | 0.040 |
Why?
|
Microspheres | 1 | 2020 | 788 | 0.040 |
Why?
|
Adiponectin | 1 | 2023 | 1117 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2022 | 603 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2021 | 1609 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 969 | 0.030 |
Why?
|
Autophagy | 1 | 2024 | 1349 | 0.030 |
Why?
|
Time Factors | 1 | 2018 | 40218 | 0.030 |
Why?
|
Muscles | 1 | 2021 | 1582 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1716 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2018 | 760 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4354 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2016 | 131 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1743 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2024 | 3428 | 0.030 |
Why?
|
Survival Rate | 1 | 2010 | 12840 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2020 | 541 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2008 | 5151 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2024 | 2885 | 0.030 |
Why?
|
Age Factors | 2 | 2024 | 18412 | 0.030 |
Why?
|
Hydrogels | 1 | 2020 | 744 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2479 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5863 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3623 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1906 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1805 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2394 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2732 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1613 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2020 | 6231 | 0.020 |
Why?
|
Quality of Life | 2 | 2021 | 13490 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2005 | 3986 | 0.020 |
Why?
|
Biopsy | 2 | 2016 | 6793 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2016 | 914 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2536 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54926 | 0.020 |
Why?
|
Radiography | 1 | 2019 | 6983 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10101 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15948 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9263 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12077 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21538 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10632 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12543 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10474 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13290 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 22291 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17140 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 89169 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13671 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20227 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1156 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2008 | 1903 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 36743 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6514 | 0.010 |
Why?
|
Mice | 1 | 2020 | 82029 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21206 | 0.010 |
Why?
|
HIV Infections | 1 | 2008 | 17569 | 0.000 |
Why?
|